Teleflex Incorporated (TFX)
| Market Cap | 5.65B +2.0% |
| Revenue (ttm) | 2.13B +54.6% |
| Net Income | -1.01B |
| EPS | -22.80 |
| Shares Out | 44.27M |
| PE Ratio | n/a |
| Forward PE | 16.87 |
| Dividend | $1.36 (1.07%) |
| Ex-Dividend Date | May 22, 2026 |
| Volume | 760,206 |
| Open | 127.94 |
| Previous Close | 128.64 |
| Day's Range | 124.99 - 129.01 |
| 52-Week Range | 100.18 - 139.67 |
| Beta | 0.82 |
| Analysts | Hold |
| Price Target | 143.67 (+12.62%) |
| Earnings Date | May 7, 2026 |
About TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and col... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for TFX stock is "Hold." The 12-month stock price target is $143.67, which is an increase of 12.62% from the latest price.
News
Teleflex announces private offering of $500M of senior notes
Teleflex (TFX) Incorporated announced the commencement of a private offering of $500M aggregate principal amount of senior notes due 2032, subject to market and other conditions. The interest rate and...
Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the commencement of a private offering of $500.0 million aggregate principal amount of senior notes due 2032...
Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the Interventional Urology Business Unit has released new clinical da...
Teleflex Announces Quarterly Dividend
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. Th...
Teleflex price target raised to $150 from $128 at Raymond James
Raymond James analyst Jayson Bedford raised the firm’s price target on Teleflex (TFX) to $150 from $128 and keeps an Outperform rating on the shares. The Q1 results were “encouraging,”…
Teleflex price target raised to $140 from $135 at Mizuho
Mizuho raised the firm’s price target on Teleflex (TFX) to $140 from $135 and keeps a Neutral rating on the shares.
Teleflex upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital analyst Shagun Singh upgraded Teleflex (TFX) to Outperform from Sector Perform with a price target of $155, up from $135. The firm says the company is making progress…
Teleflex reports Q1 adjusted EPS $1.39, consensus $1.22
Reports Q1 revenue $548.3M, consensus $537.59M. “Our Q1 performance reflects disciplined execution and meaningful progress against our transformation plan,” said CEO Stuart Randle. “We delivered a str...
Teleflex still sees 2026 adjusted EPS view $6.25-$6.55, consensus $6.72
Still sees 2026 revenue growth view of 14.4%-15.4% from 2025 revenue of $1.98B, consensus $2.29B.
Teleflex Earnings Call Transcript: Q1 2026
Q1 2026 saw 32.3% revenue growth (GAAP) and 5.1% pro forma adjusted growth, with adjusted EPS down 3.5% year-over-year. Strategic divestitures and restructuring are on track, with significant margin and EPS improvements expected in 2027.
Teleflex Earnings release: Q1 2026
Teleflex released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Teleflex Slides: Q1 2026
Teleflex has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
Teleflex Quarterly report: Q1 2026
Teleflex has published its Q1 2026 quarterly earnings report on May 7, 2026.
Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 31, 2026. First quarter 2026 continuing operations fi...
Teleflex names Jason Weidman as President and CEO
Teleflex (TFX) announced that Jason Weidman has been appointed President and CEO, effective June 8. He will succeed Stuart Randle, who has been serving as Interim President and CEO since…
Teleflex Appoints Jason Weidman as President and CEO
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) today announced that Jason Weidman has been appointed President and Chief Executive Officer, effective June 8, 2026. He will succeed Stua...
Teleflex Announces First Quarter 2026 Earnings Conference Call Information
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on ...
This Is Why Teleflex Stock (TFX) Rallied Today
Teleflex stock gained on Wednesday alongside of reports of a bid to take the company private.
CVC, GTCR weigh taking Teleflex private, Bloomberg News reports
Private equity firms CVC and GTCR are weighing a takeover of medical equipment provider Teleflex , Bloomberg News reported on Tuesday, citing people familiar with the matter.
CVC and GTCR considering Teleflex takeover, Bloomberg reports
17:59 EDT CVC and GTCR considering Teleflex (TFX) takeover, Bloomberg reports
Teleflex Incorporated Investigated by the Portnoy Law Firm
LOS ANGELES, April 17, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Teleflex Incorporated , (“ Teleflex " or the "Company") ( NYSE : TFX) investors that the firm has initiated an investigati...
Teleflex price target raised to $135 from $125 at RBC Capital
RBC Capital raised the firm’s price target on Teleflex (TFX) to $135 from $125 and keeps a Sector Perform rating on the shares as part of a broader research note…
Teleflex Proxy statement: Proxy filing
Teleflex filed a proxy statement on April 13, 2026, providing details for shareholder voting and corporate governance matters.
Teleflex upgraded to Neutral from Underperform at BofA
BofA analyst Travis Steed upgraded Teleflex (TFX) to Neutral from Underperform with a price target of $135, up from $122. While there are still execution risks, the firm sees these…
